Ophthalmology and optometry practices operate dual revenue streams — the clinical practice and the optical dispensary — each with distinct administrative requirements, billing rules, and compliance obligations. Layered on top is the specific complexity of anti-VEGF intravitreal injection programs for age-related macular degeneration and diabetic retinopathy, where prior authorization delays mean vision loss. Virtual assistants trained in eye care practice operations are managing all three administrative domains efficiently, protecting both clinical and retail revenue.
Optical Dispensary Administration Is a Retail Operation With Healthcare Complexity
The American Academy of Ophthalmology (AAO) reports that over 40 million Americans wear corrective eyewear, with dispensary revenue representing 30–50% of total revenue for comprehensive ophthalmology and optometry practices. Yet optical dispensary administration — frame inventory management, insurance benefit verification for optical coverage, lab order tracking, and patient notification when eyewear is ready — is frequently managed by opticians whose time would be better spent on patient-facing fitting and adjustment work.
Insurance verification for optical benefits is particularly complex: vision insurance (VSP, EyeMed, Davis Vision, Spectera) operates on a separate billing platform from medical insurance, with distinct eligibility rules, copay structures, and frame/lens allowances that change annually. Errors in benefit verification lead to balance billing disputes and patient dissatisfaction.
An ophthalmology VA manages the administrative layer of optical dispensary operations: verifying vision insurance benefits before appointments, tracking lab orders and delivery timelines, sending patient notification when eyewear arrives, and managing the administrative side of frame returns and remakes. Working in platforms like Eyefinity, RevolutionEHR, or Compulink, they free opticians to focus on the chair-side work that drives patient satisfaction and frame capture rate. MGMA data shows practices with structured dispensary follow-up workflows achieve 8–12% higher capture rates than those relying on passive patient recall.
Anti-VEGF Intravitreal Injection Prior Authorization Cannot Wait
Anti-VEGF medications — ranibizumab (Lucentis), aflibercept (Eylea), bevacizumab (Avastin), faricimab (Vabysmo) — are the standard of care for neovascular age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. These intravitreal injections are typically administered monthly or every 2–3 months, and treatment interruption due to authorization delays leads directly to measurable vision loss.
AAO data shows that anti-VEGF injection programs at retina practices require 30–80 authorization requests per month, with commercial payers frequently requiring step-therapy documentation, visual acuity measurements, OCT imaging reports, and prior treatment history. CMS covers anti-VEGF injections under Part B with different documentation requirements than commercial plans — and Medicare Advantage plans add another layer of plan-specific criteria.
A retina-trained ophthalmology VA maintains an injection authorization tracker organized by patient, drug, payer, and injection date. They manage submissions through Availity or payer portals, pull OCT reports and visual acuity documentation from the EHR (Epic, ModMed Ophthalmology, or Nextech), track approval timelines against scheduled injection dates, and escalate approaching deadlines to the billing coordinator. The result is elimination of treatment gaps attributable to authorization administrative failures — protecting both patient vision and injection program revenue.
DME Billing for Low Vision Aids Requires Specialty Compliance Knowledge
Low vision aids — magnifiers, telescopes, electronic magnification devices — qualify as durable medical equipment (DME) under Medicare Part B and many commercial plans, requiring DME supplier enrollment, Certificate of Medical Necessity (CMN) documentation, and compliance with DMEPOS quality standards. For ophthalmology practices with low vision programs, DME billing complexity is a significant administrative challenge.
CMS DMEPOS regulations require specific documentation: a face-to-face evaluation, a written order from the treating physician, proof of medical necessity, and in some cases a CMN signed by the physician. Errors in DME claim submission result in denial rates significantly higher than standard professional claims — MGMA data shows DME denial rates average 18–22% for practices without dedicated DME billing expertise.
An ophthalmology VA trained in DME billing manages the documentation workflow for low vision aid dispensing: tracking CMN completion, ensuring orders are appropriately documented in the EHR, submitting claims through the correct DME MAC (Durable Medical Equipment Medicare Administrative Contractor), and managing denials and appeals. This administrative discipline protects a revenue stream that many practices leave partially uncollected.
Protecting the Full Revenue Cycle of Eye Care Practices
AAO projects continued growth in retinal disease and low vision demand as the population ages and diabetic disease burden increases. Practices that build VA-supported administrative infrastructure across optical dispensary operations, injection program authorization, and DME billing will capture the full value of their clinical services. Stealth Agents provides ophthalmology-trained VAs matched to Eyefinity, ModMed Ophthalmology, and Epic workflows.
Sources
- American Academy of Ophthalmology (AAO). AAO 2025 Eye Disease Prevalence and Practice Benchmark Data. aao.org
- MGMA. Ophthalmology and Optometry Practice Operations Report 2025. mgma.com
- CMS. DMEPOS Quality Standards and Certificate of Medical Necessity Requirements. cms.gov
- Eyefinity. Optical Dispensary Practice Management Platform Overview. eyefinity.com